WVE

7.18

3.88% -0.29

Pre-mercato: 7.25 0.07 +0.97%

Wave Life Sciences Ltd (WVE)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché WVE Giù? Forum Previsione

Precedente Chiudi:

$7.47

Aprire:

$7.53

Volume 24 ore:

3.19M

Relative Volume:

0.77

Capitalizzazione di mercato:

$1.38B

Reddito:

$71.80M

Utile/perdita netta:

$-183.59M

Rapporto P/E:

-6.8102

EPS:

-1.0543

Flusso di cassa netto:

$-186.52M

1 W Prestazione:

-4.52%

1M Prestazione:

-1.37%

6M Prestazione:

-10.70%

1 anno Prestazione:

-7.12%

Intervallo 1D:

$7.025

$7.615

Intervallo di 1 settimana:

$6.92

$7.615

Portata 52W:

$5.02

$21.73

Wave Life Sciences Ltd Stock (WVE) Company Profile

Nome

Wave Life Sciences Ltd

Settore

Healthcare (1106)

Industria

Biotechnology (615)

Telefono

617-949-2900

Indirizzo

7 STRAITS VIEW, SINGAPORE

Dipendente

317

Cinguettio

@WAVELifeSci

Prossima data di guadagno

2026-04-28

Ultimi documenti SEC

WVE's Discussions on Twitter

Compare WVE vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
WVE Wave Life Sciences Ltd	7.18	1.38B	71.80M	-183.59M	-186.52M	-1.0543
VRTX Vertex Pharmaceuticals Inc	424.36	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	702.27	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	794.70	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	301.11	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	297.49	33.06B	5.36B	287.73M	924.18M	2.5229

Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-05	Iniziato	BofA Securities	Buy
2025-12-12	Reiterato	Wedbush	Outperform
2025-12-09	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2025-10-20	Iniziato	Wells Fargo	Overweight
2025-08-04	Iniziato	Canaccord Genuity	Buy
2025-07-28	Iniziato	Oppenheimer	Outperform
2025-07-16	Iniziato	Citigroup	Buy
2025-06-11	Ripresa	Raymond James	Outperform
2025-04-29	Iniziato	Cantor Fitzgerald	Overweight
2025-04-08	Iniziato	Wedbush	Outperform
2025-02-25	Iniziato	Jefferies	Buy
2024-10-16	Aggiornamento	Raymond James	Outperform → Strong Buy
2024-09-27	Ripresa	JP Morgan	Overweight
2024-09-19	Iniziato	B. Riley Securities	Buy
2024-09-09	Iniziato	JP Morgan	Overweight
2024-05-15	Iniziato	Wells Fargo	Overweight
2023-12-19	Aggiornamento	Leerink Partners	Market Perform → Outperform
2023-07-05	Iniziato	Raymond James	Outperform
2023-05-24	Downgrade	Jefferies	Buy → Hold
2020-12-15	Ripresa	H.C. Wainwright	Buy
2020-10-23	Iniziato	RBC Capital Mkts	Sector Perform
2019-12-31	Downgrade	SVB Leerink	Outperform → Mkt Perform
2019-11-01	Iniziato	Guggenheim	Buy
2019-07-15	Iniziato	Cowen	Market Perform
2019-04-17	Reiterato	H.C. Wainwright	Buy
2018-08-07	Iniziato	Stifel	Buy
2018-07-23	Iniziato	H.C. Wainwright	Buy
2018-03-19	Reiterato	Mizuho	Buy
2017-02-15	Iniziato	H.C. Wainwright	Buy
2016-11-10	Ripresa	Leerink Partners	Outperform
2015-12-07	Iniziato	JMP Securities	Mkt Outperform
2015-12-07	Iniziato	Jefferies	Buy
2015-12-07	Iniziato	Leerink Partners	Outperform
2015-12-07	Iniziato	Sun Trust Rbsn Humphrey	Buy

Mostra tutto

Wave Life Sciences Ltd Borsa (WVE) Ultime notizie

May 03, 2026

Wave Life Sciences to present WVE-006 trial data at ATS - Investing.com

May 03, 2026

May 02, 2026

Pictet Asset Management Holding SA Purchases 790,175 Shares of WAVE Life Sciences Ltd. $WVE - MarketBeat

May 02, 2026

A Look At Wave Life Sciences (WVE) Valuation After Q1 2026 Results And RNA Pipeline Progress - simplywall.st

May 02, 2026

WAVE Life Sciences (NASDAQ:WVE) Upgraded to "Hold" at Wall Street Zen - MarketBeat

May 02, 2026

WAVE Life Sciences Ltd. (NASDAQ:WVE) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

May 02, 2026

May 01, 2026

Wave Life Sciences (NASDAQ: WVE) proposes one‑for‑one redomiciliation to Delaware - Stock Titan

May 01, 2026

Wave Life Sciences 2025 Executive Compensation, Governance, and Business Highlights – 10-K/A Report - Minichart

May 01, 2026

MSN Money - MSN

May 01, 2026

Apr 30, 2026

Canaccord lowers Wave Life Sciences stock price target on valuation By Investing.com - Investing.com India

Apr 30, 2026

WVE Maintained by Canaccord Genuity -- Price Target Lowered to $43.00 - GuruFocus

Apr 30, 2026

Wave Life Sciences Signals Momentum In Earnings Call - The Globe and Mail

Apr 30, 2026

Wave Life Sciences : Amendment to Annual Report (Form 10-K/A) - marketscreener.com

Apr 30, 2026

Wave Life Sciences (Nasdaq: WVE) details 2025 milestones, cash and executive pay - Stock Titan

Apr 30, 2026

Wave Life Sciences Ltd. (NASDAQ:WVE) Q1 2026 Earnings Call Transcript - Insider Monkey

Apr 30, 2026

B. Riley Securities Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $31 - Moomoo

Apr 30, 2026

A Quick Look at Today's Ratings for Wave Life Sciences(WVE.US), With a Forecast Between $15 to $43 - Moomoo

Apr 30, 2026

Canaccord lowers Wave Life Sciences stock price target on valuation - Investing.com

Apr 30, 2026

WVE SEC FilingsWave Life Scienc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 30, 2026

Does Strong Q1 2026 Beat and Narrower Loss Reshape The Bull Case For Wave Life Sciences (WVE)? - simplywall.st

Apr 30, 2026

Apr 29, 2026

Duchenne Muscular Dystrophy Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Vertex Pharma, Bioleaders Corp., Wave Life Sciences, REGENXBIO - Barchart.com

Apr 29, 2026

RBC Capital Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $15 - Moomoo

Apr 29, 2026

WAVE Life Sciences (NASDAQ:WVE) Shares Down 7.6%Here's What Happened - MarketBeat

Apr 29, 2026

B. Riley Securities Maintains Wave Life Sciences(WVE.US) With Buy Rating, Cuts Target Price to $31 - Moomoo

Apr 29, 2026

WAVE Life Sciences (NASDAQ:WVE) Posts Quarterly Earnings Results, Beats Expectations By $0.21 EPS - MarketBeat

Apr 29, 2026

WVE Maintained by Truist Securities -- Price Target Lowered to $15 - GuruFocus

Apr 29, 2026

A Quick Look at Today's Ratings for Wave Life Sciences(WVE.US), With a Forecast Between $15 to $36 - Moomoo

Apr 29, 2026

Truist Financial Initiates Wave Life Sciences(WVE.US) With Buy Rating, Announces Target Price $15 - Moomoo

Apr 29, 2026

Wave Life Sciences Ltd. Q1 2026 Earnings Call Summary - Yahoo Finance

Apr 29, 2026

Wave Life Sciences: Q1 Earnings Snapshot - theheraldreview.com

Apr 29, 2026

Truist assumes coverage on Wave Life Sciences stock with buy rating - Investing.com India

Apr 29, 2026